Implants News and Research

RSS

New treatment using naltrexone implants can reduce heroin dependency: Study

A new treatment using naltrexone implants could lead to a significant reduction in heroin dependency. According to the researchers responsible for a recent Norwegian study, this should have major implications for the treatment options offered to heroin-dependent patients.

16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

FDA clears ArthroCare's Spartan 5.5 Needled Anchor

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration for its Spartan 5.5 Needled Anchor. Spartan is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

15 Feb 2011

Aesthetic and dental surgical procedures show greater than average growth

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, standouts in surgical procedures in terms of growth over the next five years are going to be dental implant, facial injectable, optical coherence tomography (OCT) catheter, spinal nonfusion implant, and percutaneous heart valve procedures in North America.

15 Feb 2011

New algorithm guides plastic surgeons in managing women with ALCL after breast augmentation

In the wake of a recent FDA statement linking breast implants to a rare cancer called anaplastic large cell lymphoma, a newly updated algorithm provides plastic surgeons with guidance in managing women with breast lumps or swelling after breast augmentation.

15 Feb 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Sonoma announces closing of $22 million Series D financing

Sonoma Orthopedic Products announced that it has closed a $22 million Series D financing round led by Ascension Health Ventures (AHV). Also participating in the round were Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners.

14 Feb 2011

Kyocera and JMM open new Orthopedic Design Center in the U.S.

Kyocera Industrial Ceramics Corp., Orthopedic Division, today unveiled its new Orthopedic Design Center in Somerset, N.J., formed in collaboration with Japan Medical Materials Corporation (JMM) - a Kyocera Group company.

14 Feb 2011

SpineSmith to rollout VisuALIF stand alone device for intervertebral body fusion of lumbar spine

SpineSmith, a Texas-based medical device company, today announces the company will begin the national rollout in March of the VisuALIF, following a successful Alpha launch.

14 Feb 2011

ArthroCare fourth quarter total revenue increases to $92.6 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010.

14 Feb 2011

Vitalitec announces acquisition of Novare's ENCLOSE II Anastomosis Assist Device

Vitalitec International, Plymouth, Massachusetts, is pleased to announce the acquisition of the ENCLOSE II Anastomosis Assist Device from Novare Surgical Systems. The ENCLOSE II Anastomosis Assist Device was developed by Thomas Fogarty, MD, and is designed to assist surgeons in performing "off pump" Coronary Artery Bypass Procedures.

14 Feb 2011

Sonoma acquires NovaLign Orthopaedics

Sonoma Orthopedic Products announced that it has completed the acquisition of certain key assets of NovaLign Orthopaedics, Inc.

14 Feb 2011

FDA grants Stryker 510(k) clearance for MDM X3 Mobile Bearing Hip System

Stryker Corporation's Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System. MDM X3 is an addition to the company's portfolio of next-generation technologies designed to minimize the risks traditionally associated with hip replacement surgery and address a broader patient population, including both primary and revision total hip arthroplasty candidates.

From Stryker 11 Feb 2011

Sorin's 2010 consolidated revenues increase 4.9% to € 745.8 million

The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.

11 Feb 2011

AAOS appreciates FDA's communication on metal-on-metal hip components in total hip arthroplasty

The U.S. Food and Drug Administration (FDA) today posted a public health communication about metal-on-metal hip components used in total hip arthroplasty (THA). The American Academy of Orthopaedic Surgeons (AAOS) appreciates this thorough and well-considered look at the concerns surrounding the use of these implants.

11 Feb 2011

TMJ Medical receives FDA postmarket surveillance study order

TMJ Medical acknowledged Tuesday receiving a postmarket surveillance study order from the U.S. Food and Drug Administration. TMJ Medical is one of three medical device manufacturers approved to market temporomandibular joint (TMJ) implants in the United States. Each manufacturer received the same FDA order.

10 Feb 2011

Artimplant fourth quarter net revenue decreases to SEK 3.5 million

Net revenue for the fourth quarter amounted to SEK 3.5 million (5.8) and for January-December SEK 18.5 million (24.0).

10 Feb 2011

Globus Medical's Pivot system infringes Medtronic patents, confirms US Appeals Court

Medtronic announced today that the United States Court of Appeals for the Federal Circuit affirmed that the Pivot system offered by Globus Medical infringes two patents owned by Medtronic.

10 Feb 2011

DENTSPLY 2010 net sales increase 2.9% to record $2.221 billion

DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.

9 Feb 2011

U.S. FDA orders three TMJ implant manufacturers to conduct postmarket surveillance studies

Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.

8 Feb 2011